1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Drug Focus APRIL 2016

Autoimmune Drug Focus APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Brief - Biocon's Insulin Glargine Secures Japanese Marketing Clearance
Industry Brief - First Subject Treated In CLBS03 Phase II Type I Diabetes Trial
Industry Brief - Intrexon To Develop ActoBiotics-Based Therapy For Type 1 Diabetes
Industry Brief - Lannett To Co-Develop Insulin Product
Industry Trend Analysis - Lialda Weathers Generic Storms But Remains At Threat From PTO Ruling
Industry Brief - Humira Gains CHMP Positive Opinion To Treat CD In Paediatric Patients
Industry Brief - FDA Grants Fast Track Designation To MediciNova's MN-166 For Progressive MS
Industry Trend Analysis - Novel MS Therapies Are Driving Changing Market Dynamics
Industry Trend Analysis - Intensifying Competition In MS Will Encourage Focus On Unmet Needs
Industry Brief - Additional Dosage Strengths Of Otrexup Injection FDA-Approved
Industry Brief - EMA Accepts Xeljanz MAA In RA For Review
Industry Brief - Cimzia/Humira Phase IV EXXELERATE Trial Fails To Meet Primary Endpoint In Bio-Naive RA
Industry Brief - Denosumab Effective In Preventing Structural Joint Damage In RA Patients
Industry Brief - Positive Top-Line Results Announced From Tofacitinib Phase III PsA Trial
Industry Trend Analysis - US Infliximab Approval Will Be A Boon For Pfizer And Celltrion
Industry Brief - Samsung Bioepis Infliximab Gains Positive CHMP Opinion
Industry Brief - Eli Lilly Gains FDA Taltz Approval For Moderate-To-Severe Plaque Psoriasis
Industry Brief - Cipher Launches Beteflam In Canada
Industry Brief - Japanese Marketing Green Light For Marduox To Treat Psoriasis Vulgaris
Industry Brief - Chugai Gains Japanese Maxacalcitol Patent Battle Win
Industry Trend Analysis - Dr Reddy's Sees New Horizon In XP23829
Industry Brief - Enstilar Granted UK Marketing Authorisation To Treat Psoriasis
Industry Brief - Syntimmune Secures Second Tranche Of Series A Financing
Industry Brief - DSMB Recommends Continuation Of Voclosporin Phase IIb AURA Study
Industry Brief - EC Approves Revolade To Treat Paediatric Chronic ITP
Industry Brief - Fibrocell Receives FDA ODD To Treat Localised Scleroderma
Industry Trend Analysis - Spin-Off Reveals Evotec's Confidence In Autoimmune R&D
Industry Brief - BMS To Acquire US-Based Padlock Therapeutics
Industry Brief - BMS Competes Padlock Acquisition
Industry Brief - PeptiMimesis Secures Funds To Support Transmembrane Peptides Research
Industry Trend Analysis - Autoimmune Drugs Show Signs Of Stagnation For Roche
Industry Brief - Autoimmune Conferences - July 2016

Table Of Contents

Autoimmune Drug Focus APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.